AGP Executive Report
Last update: 7 hours agoHIV Prevention Access: Gilead and PAHO agreed on a regional pathway to widen access to twice-yearly lenacapavir (Yeztugo) for HIV PrEP, using PAHO’s procurement system; the plan targets 14 Latin American and Caribbean countries, including Paraguay, to help close prevention gaps as new infections rose 13% from 2010–2024. Snakebite Preparedness: PAHO marked International Snakebite Awareness Day by reporting technical missions in Paraguay and other countries to strengthen surveillance, diagnosis, treatment protocols, and timely access to antivenoms. Bone Marrow Matching Drive: Paraguay will host a World Marrow Donor Day registration event in Asunción and Mariano Roque Alonso, using buccal swabs to grow the national donor registry and improve transplant match chances. Public Health Workforce: Paraguayan teachers mobilized for higher salaries and more education investment, rejecting a government pact they say could fracture union unity. Health Tech Caution: Apple says hypertension notifications on Apple Watch Series 12 and Ultra 4 are still pending regulatory clearances in 33 regions, including Canada and Japan.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Pharmaceutical Executive Daily: FDA Approves Fayuvi]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/24990778-912932933-69ad66ff9a88b963b53a43ee2436f89da07d52ad-1280x720-100x56.jpeg)
